Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Zhengyu Yang's publication output changed over time?
ScholarIQpublication output · 2011–2023
Output grew100% over the shown period — from 1 works in 2011 to 2 in 2023.
1
1
2
1
3
2
201120132020202120222023
What are the most-cited papers on Zhengyu Yang?
ScholarIQmost cited works
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Stefano Del Prato, Steven E. Kahn, Imre Pávó, Govinda J. Weerakkody, Zhengyu Yang, John Doupis, Diego Aizenberg, Alan Wynne, Jeffrey S. Riesmeyer, Robert J. Heine, Russell J. Wiese, Andrew Ahmann, Samir Arora, Eric Ball, Rafael Burgos-Calderón, David Butuk, Leila Chaychi, Michael C. Chen, Brian M. Curtis, Ronald H. Chochinov, Christopher Chow, Clancy Cone, Lisa Connery, Gregorio Cortes-Maisonet, José de Souza, Kathleen Dungan, David Bradley, Juan P. Frías, Nashwa Gabra, Linda Gaudiani, Luis Herandez-Vazquez, Stanley H. Hsia, Michael Jardula, E. Klein, Mark E Kutner, Juan Loy, Francisco G Miranda, Lazaro Nunez, Miguel Mujica-Baella, Alexander V. Murray, Michael Oliver, Ramon Oritz-Carrasquillo, Betsy Palal, Michael T Parke, Athena Philis‐Tsimikas, Raman Purighalla, Julio Rosenstock, Airani Sathananthan, Courtney Shelton, Kanagaratnam Sivalingam, Ehab Sorial, Joseph Soufer, Helen L Stacey, Larry D. Stonesifer, Stanley Stringam, Joanna Van, Jose Vazquez-Tanus, Ramón López de los Reyes, Michelle Welch, Najmuddin Karimjee, Earl E Martin, Ahmed A. Arif, Timothy W Jennings, Neil J. Fraser, Anuj Bhargava, Alan Wynne, Evelyne Davidson, Liana K. Billings, Elizabeth A Barranco-Santana, Michael Dever, Patrick Walsh, A.K. Cho, James W. Chu, Jay H. Shubrook, Albert B. Knouse, Venkatesh Nadar, Lorena Lewy-Alterbaum, Michael Lillestol, Daniel J Humiston, Alexander White, Ronald K. Mayfield, Fahed Bitar, Fernando Cereto, Carmen de la Cuesta, L. de Teresa Parreño, Esteban Jódar Gimeno, Pedro Mezquita‐Raya, Cristobal J Morales Portillo, Miguel Quesada Charneco, Francisco J. Tinahones, Santiago Tofe Povedano, Luis Alberto Vázquez, Carmen Fajardo Montañana, Alfonso González, Cristina Mistodie, Iosif Szilagyi, Adriana Filimon, Nicoleta Mîndrescu, Lavinia Pop, Marlena Pascu
The Lancet. 2021657 Citations
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
Hiddo J.L. Heerspink, Naveed Sattar, Imre Pávó, Axel Haupt, Kevin L. Duffin, Zhengyu Yang, Russell J. Wiese, Katherine R Tuttle, David Z.I. Cherney
The Lancet Diabetes & Endocrinology. 2022286 CitationsOPEN ACCESS
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial
Sara M. Tolaney, Andrew Wardley, Stefania Zambelli, John Hilton, Tiffany A. Troso-Sandoval, Francesco Ricci, Seock‐Ah Im, Sung‐Bae Kim, Stephen Johnston, Arlene Chan, Shom Goel, Kristen Catron, Sonya C. Chapman, Gregory L. Price, Zhengyu Yang, M. Corona Gainford, Fabrice André
The Lancet Oncology. 2020261 Citations
Global climate change and human health: Pathways and possible solutions
Qi Zhao, Pei Yu, Rahini Mahendran, Wenzhong Huang, Yuan Gao, Zhengyu Yang, Tingting Ye, Bo Wen, Yao Wu, Shanshan Li, Yuming Guo
S4220651295. 2022236 CitationsOPEN ACCESS
Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
Matthew R. Alexander, Christopher W. Moehle, Jason L. Johnson, Zhengyu Yang, Jae K. Lee, Christopher L. Jackson, Gary K. Owens
S114430552. 2011219 CitationsOPEN ACCESS
Related on ScholarIQ
Australian Housing and Urban Research Institute
Institution
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Paper
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
Paper
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial
Paper
Global climate change and human health: Pathways and possible solutions
Paper
Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
Paper